Randomized study of semaglutide effects on cognitive function in people with HIV finds potential neuroprotective benefits in this neurologically vulnerable population.
Key findingRandomized study of semaglutide effects on cognitive function in people with HIV finds potential neu
What the researchers found
Randomized study of semaglutide effects on cognitive function in people with HIV finds potential neuroprotective benefits in this neurologically vulnerable population.
Why it matters
Relevant to peptide therapeutics.
How the study worked
In publication.
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
Effects of Semaglutide on Cognitive Function in People with HIV: A Randomized Controlled Trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Citation
Atieh, Ornina; Daher, Joviane; Abboud, Marc; Wu, Qian; Sattar, Abdus; Baissary, Jhony; Koberssy, Ziad; Labbato, Danielle; Eckard, Allison Ross; McComsey, Grace A. (2025). Effects of Semaglutide on Cognitive Function in People with HIV: A Randomized Controlled Trial.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciaf577